Internal Medicine, Cardiovascular Disease · Daytona Beach, FL
NPI
1417921701
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
311 N Clyde Morris Blvd Ste 320
Daytona Beach, FL, 32114
Phone (386) 255-5331
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
13,635 services
Medicare patients, 2024
2,179
Average age 77
Drug cost, 2024
$3.4M
15,174 prescriptions
Company payments, 2025
$828
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Humayun Jamidar was code 93000 (electrocardiogram), 2,636 times for 1,884 patients. In total Humayun Jamidar billed 13,635 services in 64 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 2,636 | 1,884 | $10.20 | $27K |
| 99214 Office E&M - Established | Office | 2,500 | 1,771 | $95.66 | $239K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,148 | 287 | $5.72 | $6,566 |
| 93306 Echocardiography (TTE/TEE) | Office | 1,128 | 1,083 | $133.73 | $151K |
| 93793 Care Management/Coordination | Office | 641 | 37 | $8.33 | $5,339 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 546 | 532 | $139.22 | $76K |
| 93888 Ultrasound - Nonspecific | Office | 467 | 453 | $89.72 | $42K |
| 93015 Electrocardiogram | Office | 388 | 365 | $50.73 | $20K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 384 | 192 | $312.86 | $120K |
| 93298 External Electrocardiographic Monitoring | Office | 274 | 45 | $74.51 | $20K |
| 85610 Clinical Chemistry | Office | 249 | 22 | $4.20 | $1,046 |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 121 | $61.08 | $15K |
| 93296 External Electrocardiographic Monitoring | Office | 223 | 110 | $15.14 | $3,377 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 222 | 111 | $168.56 | $37K |
| 99204 Office E&M - New | Office | 213 | 213 | $124.61 | $27K |
By year: 2022 $1.5M for 16,180 services; 2023 $1.7M for 16,871 services; 2024 $1.4M for 13,635 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 249 | 22 | $4.20 | $1,046 |
Medicare prescription drug claims, 2024
In 2024, the drug Humayun Jamidar prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,405 prescriptions and refills. In total Humayun Jamidar wrote 15,174 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,405 | 2,865 | 325 | $1.6M |
| Amlodipine Besylate Generic | 1,196 | 3,453 | 395 | $8,823 |
| Metoprolol Tartrate Generic | 1,095 | 3,090 | 339 | $8,038 |
| Rosuvastatin Calcium Generic | 1,049 | 3,061 | 333 | $16K |
| Losartan Potassium Generic | 901 | 2,628 | 289 | $11K |
| Atorvastatin Calcium Generic | 662 | 1,958 | 201 | $8,061 |
| Lisinopril Generic | 571 | 1,596 | 179 | $5,627 |
| Furosemide Generic | 514 | 1,312 | 193 | $2,747 |
| Doxazosin Mesylate Generic | 510 | 1,471 | 159 | $9,527 |
| Clopidogrel Clopidogrel Bisulfate | 475 | 1,364 | 141 | $5,103 |
| Carvedilol Generic | 443 | 1,265 | 134 | $5,068 |
| Metoprolol Succinate Generic | 426 | 1,239 | 132 | $7,117 |
| Repatha Sureclick Evolocumab | 372 | 590 | 73 | $331K |
| Spironolactone Generic | 367 | 1,080 | 138 | $4,396 |
| Xarelto Rivaroxaban | 349 | 828 | 100 | $451K |
Brand drugs: 3,092 claims; generic drugs: 12,082 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Humayun Jamidar $828 ($828 in general payments such as food, travel and fees) from 17 companies. The largest payer was Medtronic, Inc. with $160.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $160 |
| Boston Scientific Corporation BSX | 4 | $134 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $93.95 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $69.24 |
| Pfizer Inc. PFE | 4 | $68.37 |
| Kestra Medical Technology Services, Inc. | 2 | $50.66 |
| CVRx, Inc. CVRX | 2 | $47.2 |
| Merck Sharp & Dohme LLC MRK | 2 | $46.01 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.64 |
| Abbott Laboratories ABT | 1 | $21.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.